Edwards Lifesciences Enterprise Value over EBIT Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 111.2  1.88  1.66%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value over EBIT of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earning Before Interest and Taxes USD.
Enterprise Value over EBIT  10 Years Trend  
Decreasing
Slightly volatile
 Enterprise Value over EBIT 
      Timeline 

Edwards Lifesciences Enterprise Value over EBIT Over Time

2015-12-31  26 
2016-12-31  26 
2017-12-31  19.47 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  31.62
Geometric Mean  23.38
Coefficient Of Variation  119.79
Mean Deviation  19.96
Median  26
Standard Deviation  37.88
Sample Variance  1,435
Range  139
R Value (0.45)
Mean Square Error  1,253
R Squared  0.21
Significance  0.14
Slope (4.77)
Total Sum of Squares  15,785

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 107.02
GOOG   
 NMS 
Purchased few shares of
a day ago ago
Traded for 984.45
VMW   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 117.4